# Omacor and Placebo in Carotid Plaque Stability

> **NCT00294216** · PHASE3 · COMPLETED · sponsor: **Pronova BioPharma** · enrollment: 121 (—)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Omega-3-acid ethyl ester 90 (n-3 PUFA)

## Key facts

- **NCT ID:** NCT00294216
- **Lead sponsor:** Pronova BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 121 (—)
- **Last updated:** 2006-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00294216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00294216, "Omacor and Placebo in Carotid Plaque Stability". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00294216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*